Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Active, not recruiting · NCT03384914 · Registry updated 2026-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | HER2 positive breast carcinoma, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, male breast carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-03-06 | NCT03384914 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
| United States Department of Defense | 319 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory - Winship Cancer Institute | Atlanta | United States | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | United States | 32 |
| Indiana University - Melvin and Bren Simon Cancer Center | Indianapolis | United States | 2 |
| Ohio State University - Arthur G James Cancer Hospital & Richard J Solove Research Institute | Columbus | United States | 1 |
| Roswell Park Comprehensive Cancer Center | Buffalo | United States | 63 |
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| University of Washington, Fred Hutchinson Cancer Research Center | Seattle | United States | 1 |